ATC level 4
L01FFCancer medicines (antineoplastics), subgroup L01F, subgroup L01FF
- Molecules
- 11
- Subgroups
- 11
ATC L01FF (Cancer medicines (antineoplastics), subgroup L01F, subgroup L01FF) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 11 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L01FF.
- AtezolizumabOrphanAntibodies2 presentations2 brandsL01FF05
- AvelumabOrphanAntibodies1 presentation2 brandsL01FF04
- DostarlimabBiologicProgrammed Death Receptor-1 Blocking Antibody1 presentation2 brandsL01FF07
- DurvalumabOrphanAntibodies2 presentations2 brandsL01FF03
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
- RetifanlimabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation2 brandsL01FF10
- Serplulimab1 brandL01FF12
- Sugemalimab1 brandL01FF11
- TislelizumabOrphanProgrammed Death Receptor-1 Blocking Antibody2 presentations2 brandsL01FF09
- ToripalimabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation2 brandsL01FF13
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.